6-methyl-1,3,8-trichlorodibenzofuran has been researched along with kynurenine in 1 studies
| Studies (6-methyl-1,3,8-trichlorodibenzofuran) | Trials (6-methyl-1,3,8-trichlorodibenzofuran) | Recent Studies (post-2010) (6-methyl-1,3,8-trichlorodibenzofuran) | Studies (kynurenine) | Trials (kynurenine) | Recent Studies (post-2010) (kynurenine) |
|---|---|---|---|---|---|
| 25 | 0 | 3 | 7 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballarotto, M; Dolciami, D; Fallarino, F; Gargaro, M; López-Cara, LC; Macchiarulo, A | 1 |
1 review(s) available for 6-methyl-1,3,8-trichlorodibenzofuran and kynurenine
| Article | Year |
|---|---|
Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs).
Topics: Animals; Humans; Immune System Diseases; Immunotherapy; Ligands; Molecular Structure; Receptors, Aryl Hydrocarbon | 2020 |